Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 months
- PMID: 39781494
- PMCID: PMC11704083
- DOI: 10.1016/j.ccrj.2024.08.006
Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 months
Abstract
Objective: Extracorporeal membrane oxygenation (ECMO) is a high-risk procedure with significant morbidity and mortality and there is an uncertain volume-outcome relationship, especially regarding long-term functional outcomes. The aim of this study was to examine the association between ECMO centre volume and long-term death and disability outcomes.
Design setting and participants: This is a registry-embedded observational cohort study. Patients were included if they were enrolled in the binational ECMO registry (EXCEL). The exclusion criteria included patients on ECMO for heart/lung transplants. Data included demographics, clinical information on their first ECMO run, and six-month outcomes obtained by telephone interview. The primary outcome was death or new disability at six months. A multivariable analysis was conducted using hospitals' annual ECMO volume. High-volume centres were defined as having >30 ECMO cases annually, and analyses were run on ECMO subgroups of veno-venous (VV), veno-arterial (VA), and extracorporeal cardiopulmonary resuscitation (ECPR).
Results: Of 1232 patients, 663 patients were cared for on ECMO at high-volume centres and 569 patients at low-volume centres. There was no difference in six-month death or new disability between high- and low-volume ECMO centres in VV-ECMO [OR: 1.09 (0.65-1.83), p = 0.744], VA-ECMO [OR: 1.10 (0.66-1.84), p = 0.708], and ECPR-ECMO [OR: 1.38 (0.37-5.08), p = 0.629]. This finding was persistent in all sensitivity analyses, including exclusion of patients who were transferred between high- and low-volume centres.
Conclusion: There was no difference in death or disability at six months between high- and low-volume centres in Australia and New Zealand, possibly due to the current model of coordinated care that includes patient transfers and training between high- and low-volume ECMO centres in our region.
Keywords: Acute respiratory distress syndrome (ARDS); Anaesthesia and intensive care; Cardiac failure; Cardiac perfusion; Emergency medicine; Extracorporeal life support; Intensive care; Oxygen delivery; Respiratory function; Resuscitation.
© 2024 The Authors.
Conflict of interest statement
Carol L Hodgson reports financial support was provided by National Health and Medical Research Council. Carol L Hodgson reports financial support was provided by National Heart Foundation of Australia. Ary Serpa-Neto, Bentley J Fulcher, Anais Charles-Nelson, Michael J Bailey, Stephen Bernard, Aidan JC Burrell, D. James Cooper, David J Gattas, Ingrid K Hopper, David V Pilcher, Natalie J Linke, Tony V Trapani, Alisa M. Higgins reports financial support was provided by National Health and Medical Research Council. Ary Serpa-Neto, Bentley J Fulcher, Anais Charles-Nelson, Michael J Bailey, Stephen Bernard, Aidan JC Burrell, D. James Cooper, Daivd J Gattas, Ingrid K Hopper, David V Pilcher, Natalie J Linke, TOny V Trapani, Alisa M Higgins reports financial support was provided by National Heart Foundation of Australia. Carol L Hodgson reports a relationship with National Health and Medical Research Council that includes: funding grants. Carol L Hodgson reports a relationship with International ECMO Network (ECMONet) that includes: board membership. Carol L Hodgson, Ary Serpa Neto, Edward Litton, D. James Cooper, Andrew Udy reports a relationship with Critical Care and Resuscitation that includes: editorial team membership as associate editors. Alisa M Higgins, Aidan JC Burrell, D. James Cooper reports a relationship with National Health and Medical Research Council that includes: funding grants. Daniel Brodie, Eddy Fan, John F Fraser, Vincent A Pellegrino reports a relationship with International ECMO Network (ECMONet) that includes: board membership. Daniel Brodie, Eddy Fan, John F Fraser reports a relationship with Extracorporeal Life Support Organization that includes: board membership. Daniel Brodie reports a relationship with AbioMed Inc that includes: board membership. Daniel Brodie reports a relationship with Xenios AG that includes: board membership. Daniel Brodie reports a relationship with Medtronic Inc that includes: board membership. Daniel Brodie reports a relationship with Cellenkos that includes: board membership. Daniel Brodie reports a relationship with Alung Technologies that includes: funding grants. John F Fraser reports a relationship with Queensland Cardiovascular Research Network that includes: board membership. John F Fraser reports a relationship with BiVACOR that includes: board membership. John F Fraser reports a relationship with Xenios AG that includes: funding grants. John F Fraser reports a relationship with Mallenkrodt Getinge that includes: funding grants. John F Fraser reports a relationship with MERA that includes: funding grants. Dion Stub reports a relationship with National Heart Foundation of Australia that includes: funding grants. Andrew A Udy reports a relationship with Australian and New Zealand Intensive Care Society Clinical Trials Group that includes: board membership. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Extracorporeal Life Support Organization (ELSO) Extracorporeal Life Support Organization; Michigan (USA): 2023 17 October. ECLS registry report - international summary.
-
- Hodgson C.L., Higgins A.M., Bailey M.J., Anderson S., Bernard S., Fulcher B.J., et al. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. Lancet Respir Med. 2022;10(11):1038–1048. - PubMed
-
- Yeo H.J., Cho W.H., Kim D. Learning curve for multidisciplinary team setup in veno-venous extracorporeal membrane oxygenation for acute respiratory failure. Perfusion. 2019;34(1_suppl):30–38. - PubMed
LinkOut - more resources
Full Text Sources
